“Biobanks for studying

Craniosynostosis: a rare pediatric

major congenital craniofacial

disorder”

Adenylosuccinate lyase deficiency,

purine metabolism disorders and

mitochondrial homeostasis:

unveiling novel mechanisms to

design therapeutic opportunities”

3D Bioprinting as a therapeutic

innovation tool for precision

oncology

Identification of new diagnostic and

prognostic markers by

comprehensive approach of

genomic and imaging diagnosis in

pediatric tumors

Pre-clinical development and

patenting of a cellular product

based on leukemia multiantigen-

specific T cells to form a repository

of third-party allogeneic advanced therapy medicinal products for future use in the prevention of

acute myeloid leukemia relapse

after allogeneic stem cell

transplantation

New therapeutics targets with

clinical intervention for both

paediatric and adult Brain cancer

Multiomic and Imaging risk Profiling

for the Identification of

Comorbidities in Obese Children

and Adolescents using Artificial

Intelligence

Validation of an innovative

screening algorithm for early

detection of celiac disease and type

1 diabetes in the general pediatric

population

Developing a Biobank network

among major sarcoma treatment

centers to improve biomedical

research.

A dopable bioink for augmented tissue engineering in craniofacial reconstruction: innovative pipeline for drug design and selective delivery through functionalized polymeric nanoparticles

Empowering the clinical management of BMFs through a biological and genetically driven pediatric and adult national network.